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Abstract  
In this study we investigated the antihyperglycaemic, antihyperlipidaemic and antiglycation effects of some extracts of Prosthechea michuacana bulbs in 
normoglycemic and diabetic rats induced by streptozocin (STZ). Hexane, chloroform and methanol extracts of P. michuacana were screened for 
hypoglycemic activity, and biochemical parameters as serum triglycerides, total cholesterol, lipid peroxidation, liver glycogen, skeletal muscle glycogen 
levels, superoxide dismutase, catalase, glutathione reductase and glutathione peroxidase activity in diabetic rats. Additionally we determined Glucose 6 
Phosphatase and glucokinase activities in liver, inhibition of insulin and protein glycation. Glucose levels in blood plasma were determined by using GOD-
POD method. Administration of chloroform and methanol extracts showed no effect on STZ induced diabetic rats (SD). On the other hand, treatment with 
hexane extract at 200 and 400 mg/kg doses, resulted in a reversal of diabetes and its complications. Both doses significantly brought down blood glucose 
concentration (35.75 and 47.78% in diabetic rats, 50.64 and 57.10% in nondiabetic rats), increased glycogenesis and decreased glyconeogenesis bringing the 
glucose metabolism toward normalcy. These doses also reversed the hyperlipidemia by reducing cholesterol (41.56%, 46.08%) and triglycerides (37.5%, 
46.27%) and improved hepatic antioxidant enzyme activities. Its effect was compared with that of glibenclamide and tolbutamide, as reference antidiabetic 
drugs. The hexane extract decreased the hyperinsulinemia by 24% in SD and showed a significant change on AGEs formation in vitro with IC50 values of 48.3 
µg/ml comparable to inhibitory effect of aminoguanidine with IC50 values of 27.2 µg/ml. It reduced HbA1C levels by 6.4% in chronic STZ-diabetic rats. It is 
concluded that hexane extract of Prosthechea michuacana bulbs possesses anti-hyperglycemic and antihyperlipemic activity, improves the hyperinsulinemia 
and produces a significant change on AGEs formation, which may prove to be of importance in the management of diabetes and its complications. 
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Resumen 
En este estudio se determinaron los efectos antidiabéticos, antihiperlipidemico y glicación (AGEs)  de algunos extractos de Prosthechea michuacana (PM) en 
ratas normoglucémicas y con diabetes inducida por estreptozotocina (STZ). Se probó el efecto de los extractos de hexano, cloroformo, metanol de PM  sobre 
la actividad hipoglucemiante, la carga de glucosa, los parámetros bioquímicos tales como triglicéridos, niveles de colesterol total, peroxidación lipídica, 
glucógeno del hígado, los niveles de glucógeno muscular, niveles de superoxide dismutase, catalasa, glutation reductasa and glutation peroxidasa en ratas 
normales y diabéticas. También se determinó la glucosa 6 Phosphatasa y las actividades de GK en el hígado, la inhibición de la insulina y la glicosilación de 
las proteínas. Los niveles de glucosa sanguínea se determinaron por el método de GOD-POD. La administración de los extractos de cloroformo y metanol no 
presentaron ningún efecto sobre la SD, en cambio el tratamiento con el extracto de hexano (PM) a dosis de 200 y 400 mg/kg, inhibió la diabetes y sus 
complicaciones. Ambas dosis redujeron significativamente los niveles de glucosa sanguínea (35.75 y 47.78% en las ratas diabéticas, 50.64 y 57.10% en las 
ratas diabéticas), el aumento de la glucogénesis y la disminución de la gluconeogénesis conduce el metabolismo de la glucosa hacia la normalidad. Estas dosis 
disminuyeron la hiperlipidemia reduciendo el colesterol (41.56%, 46.08%) y los triglicéridos (37.5%, 46.27%) así como también mejoran las actividades 
antioxidantes de las enzimas hepáticas. Su efecto se comparó con la glibenclamida y tolbutamida, fármacos usados como antidiabeticos. El extracto de hexano 
disminuyo la hiperinsulinemia en un 24% en SD. PM mostró un cambio significativo in vitro sobre la formación de los AGEs con valores de IC50 de 48.3 
mg/ml comparable al efecto inhibidor de la aminoguanidina con valores de IC50 de 27.2 mg/ml. Se redujo en las ratas con diabetes crónica los niveles de 
HbA1C en un 6.4%. Por lo que se concluye que el extracto hexánico de los bulbos de Prosthechea michuacana posee actividad anti-hiperglucémica, 
antihiperlipemica, mejora la hiperinsulinemia mostrando un cambio significativo en la formación de AGEs, lo que puede llegar a ser de importancia en el 
tratamiento de la diabetes y sus complicaciones. 
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INTRODUCTION 
Diabetes is a serious metabolic disorder with micro 
and macro vascular complications that result in 
significant morbidity and mortality. The increasing 
number of ageing population, changes in life style 
such as preference for rich calories food and 
sedentary, obesity, have led to an increase in the 
number of diabetic patients world wide. A special diet 
and exercise are the first steps toward achieving an 
improvement in the condition of patients; still 90% of 
them are unable to maintain long-term glycemia 
(Modi, 2007). Thus hypoglycemic agents are 
necessary for the treatment of diabetes. The currently 
available ones, exhibit several undesirable side effects 
as hypoglycemia, hyponatremia, lactic acidosis and 
vitamin B12-malabsorption (Berger,1985) to mention 
just a few. Therefore, there is a need for more effective 
oral antihyperglycemic agents, particularly those that 
can normalize both insulin and glucose levels. The 
plant kingdom represents a largely unexplored 
reservoir of biologically active compounds (Valavala 
et al., 2011). A wide array of plants and their active 
principles, provide an alternative therapy for diabetes. 
Experience in traditional medicine has shown that very 
often this natural extracts produce minimal side 
effects. Diabetes is characterized by hyperglycemia 
that causes protein glycation and considerable 
pathogenesis of long-term complications; In particular, 
oxidative stress and advanced glycation end-products 
formation (AGEs) induced by hyperglycemia that are 
known to influence diabetic renal changes and 
nephropathy (Comelli et al., 2009). AGEs are the final 
products of the nonenzymatic reaction of reducing 
sugars and amino groups in proteins, lipoproteins and 
nucleic acids (Singh et al., 2001). They are a group of 
complex and heterogeneous compounds that are 
known as brown and fluorescent cross-linking 
substances such as pentoside, no fluorescent cross-
linking products like methylglyoxal-lysine dimers, 
non-cross-linking adducts such as 
carboxymethyllysine and pyrraline, a pyrrole 
aldehyde. Recently, AGEs accumulation in vivo has 
shown to play a major role in the pathogenic process 
of diabetes and its complications, including 
neuropathy, nephropathy, retinopathy, cataract 
formation and in other health disorder such as 
atherosclerosis, Alzheimer´s disease, and normal aging 
(Rahbar and Figarola, 2002). Thus, the discovery and 
investigation of compounds with an AGEs inhibitor 
activity, would certainly offer a potential therapeutic 
approach for the prevention of diabetes and its 
pathogenic complications. 
Prosthechea michuacana (Lex.) WE Higgins belongs 
to the family Orchidaceae. Mixteco and  zapoteco 
natives of Oaxaca Mexico, give to this plant several 
uses: As food they collect the bulbs to eat them raw,  
to eliminate thirst or liquefy them with water to 
prepare a beverage, that is also used as anti-
inflammatory, to depurate the circulatory system, and 
treat renal disease and diabetes. During the months of 
november and december, this beautiful orchid is used 
for religious purposes as a decorative element in the 
traditional "Birth" (Téllez-Velasco, 2001). We have 
previously reported the relaxant and antispasmodic 
effect of this plant in isolated guinea pig ileum 
(Vargas and Perez, 2009), its hepatoprotective activity, 
its ability to inhibit oxidative stress in liver (Perez and 
Vargas, 2009), its anti-inflammatory and wound 
healing properties (Perez and Vargas, 2009), its 
nephroprotective activity (Perez et al., 2010a) and its 
antioxidant activity (Perez and Neira, 2010b). The aim 
of the present study was to explore the utility of the 
orchid P. michuacana bulbs for correction of 
hyperglycemia and hyperlipidemia using a model of 
STZ-induced diabetic rats and non-diabetic rats. 
 
MATERIALS AND METHODS 
Plant material 
Prosthechea michuacana (Lex.) WE Higgins belong 
to the family Orchidaceae, bulbs were collected in the 
Mexican state of Oaxaca. Plants were taxonomically 
authenticated in the Instituto Politécnico Nacional and 
a voucher specimen of the plant is stored for reference 
(Nº 6478) in the Herbarium of the Metropolitan 
autonomous university campus Xochimilco (UAM) 
for further reference. 300 g of the aerial parts and 
bulbs were dried and powdered in a mechanical 
grinder. The powdered material was extracted with 
900 ml of hexane, chloroform and methanol 
consecutively using a soxhlet apparatus. These 
extracts were filtered and concentrated in a rotary 
vacuum evaporator and kept in a vacuum desiccator 
for complete removal of solvent. An aqueous 
suspension of each extract was prepared using 2% 
(v/v) Tween-80 and used for administration. 
 
Animals 
The study was conducted in male Wistar albino rats, 
weighing about 180 - 225 g procured by the UAM 
bioterium. Before and during the experiment, animals  
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were fed with normal laboratory diet (Mouse Chow 
5015) and water ad libitium. Animals were kept in 
microlon boxes and were acclimatized for a period of 
3 days in the new environment (temperature 25 ± 2º C) 
before initiation of experiment. The litter in their cages 
was renewed three times a week to ensure hygiene and 
maximum comfort for the animals.  Ethical clearance 
for handling animals (NIH publication No. 85-23 
revised 1985) was observed.  
 
Acute toxicity studies 
Healthy adult Wistar albino rats weighing between 
180 - 230g of either sex, fasted overnight were divided 
into four groups (n=6). They were orally fed with the 
aqueous extract of P. michuacana at increasing doses 
of 1000, 2000, 3000, mg/kg body weight (Ghosh, 
1984). The animals were observed continuously for 2 
h for behavioral, neurological and autonomic profiles 
and later after a period of 24 and 72 h for any lethality 
(Sarkhail et al., 2010).
 
 
Streptozotocin (STZ)-induced diabetic model 
Severe diabetes was induced in over night fasted male 
rats by a single intraperitoneal injection of 
streptozotocin, with a dose of 65 mg/kg body weight 
dissolved in cold citrate buffer (Nirmala et al., 2011). 
Diabetes was confirmed in the STZ-treated rats by 
measuring the fasting blood glucose concentration 1 
day after injecting the STZ. Rats with permanent high 
fasting blood glucose level > 250 mg/dl were included 
for the panel of tests of our experimental design. 
 
Effects of a single dose of the hexane, chloroform 
and methanol extracts in normal and diabetic rats 
In the experiment a total 72 rats (36 diabetic rats and 
36 non-diabetic rats) were used. The rats were divided 
into twelve groups with six animals in each group. The 
treatment was scheduled as follows: 
- Group I: non-diabetic control received only 
2% Tween-80 Solution 
- Group II: non-diabetic rats treated with P. 
Michuacana extract 100 mg/kg body weight 
- Group III: non-diabetic rats treated with P. 
Michuacana extract 200 mg/kg body weight 
- Group IV: non-diabetic rats treated with P. 
Michuacana extract 400 mg/kg body weight. 
- Group V: non-diabetic rats treated with 
tolbutamide at 40 mg/kg body weight. 
- Group VI: Diabetic control received only 2% 
Tween-80 Solution. 
- Group  VII:  Diabetic   rats   treated   with  P. 
 
Michuacana  extract 100 mg/kg body weight 
- Group VIII: Diabetic rats treated with P. 
Michuacana extract 200 mg/kg body weight. 
- Group IX: Diabetic rats treated with P. 
Michuacana extract 400 mg/kg body weight. 
- Group X: Diabetic rats treated with 
glibenclamide at 0.5 mg/kg body weight. 
-  Group XI: Diabetic rats treated with 
tolbutamide at 40 mg/kg body weight. 
Drugs solutions or vehicle were administered orally by 
gastric intubations daily at 9:00 am for a period of 28 
days.
 
Blood glucose levels were determined in fasting 
animals before initiation of the experiment and from 
then, every third day. On the 28th day, animals were 
sacrificed by an ether over-dose. Different 
biochemical parameters like serum triglycerides and 
total cholesterol, liver and skeletal muscle glycogen 
content (Kiyici et al., 2010) were essayed in the 
groups.
 
 
 
Estimation of oral glucose tolerance test  
Rats of each group were orally administered 400 
mg/kg of extracts for 28 days. At the end of the period, 
the oral glucose tolerance test (OGTT) was performed 
to assess the sensitivity to a high glucose load. For this 
purpose, overnight-fasted rats were fed orally 2 g 
glucose/kg b.w. Blood samples were collected from 
the caudal vein through a small incision at the end of 
the tail at 0 min (immediately after glucose load), 30, 
60, 90 and 120 min after glucose administration.  
 
Measurement of glucose, total cholesterol, 
triglyceride and lipid peroxidation in serum 
Rats were fasted for 18 h and blood samples were 
immediately collected by puncture of retro-orbital 
plexus with a capillary tube under ether anesthesia into 
glass vials containing potassium oxalate and sodium 
fluoride as anticoagulant at 0 h (before treatment) and 
2, 4, 6, 8, 12 h after treatment.  Plasma glucose levels 
were determined by using GOD-POD method. This 
colorimetric method is based on the enzymatic 
reactions between invertase and glucose oxidase-
peroxidase (GOD-POD) (Sang-Eun et al., 2007). 
The content of triglycerides and total 
cholesterol levels in serum were estimated with the 
respective Diagnostic Reagent Kit by Genzyme 
Diagnostics. The cholesterol kit is based on the 
cholesterol oxidase-DAOS method, wheatear the 
triglycerides kit is based on the GPO-p-chlorophenol 
method. The total lipids level were measured as a 
thiobarbituric acid (TBARS) by a LPO test (Wako 
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Pure Chemical Industries Ltd.), based on 3-α-
hydroxysteroid dehydrogenase (Fraga et al., 1988). 
 
Liver and skeletal muscle glycogen content and 
G6Pase, GK activities in liver 
Rats of each group were administered orally 400 
mg/kg of extracts for a period of 28 days, after that 
period of time, animals were sacrificed and livers were 
extracted. The glycogen content of liver and skeletal 
muscles was determined by using anthrone reagent 
(Davis and Granner, 1996). 100 mg of tissue was 
centrifuged in a tube containing 1 ml of KOH at 30%. 
The tube was kept 20 minutes in a boiling water bath, 
the digest was cooled, and 1.25 ml of 95% ethanol was 
added. The tube was boiled in a hot water bath and 
cooled again before a centrifugation of 15 min at 3000 
rpm. The supernatant was decanted and the residue 
was redissolved in 1 ml of distilled water and treated 
as before until decanted again. Sedimented glycogen 
was dissolved exactly in 5 ml of water. The tube was 
submerged in ice-cold water and 10 ml of anthrone 
was added, all was mixed by swirling the tubes. The 
cold tubes were covered with glass marbles and heated 
for 10 min in a boiling water bath. Once cooled, the 
content was measured in a spectrophotometer at 620 
nm. Results are expressed in mg/g of tissue. A 
standard curve of glycogen type III from rabbit liver 
(Sigma) was simultaneously analyzed to determine the 
final liver glycogen concentrations. 
The hepatic G6Pase activity was assayed by 
the method of Baginski et al., (1969). In brief, the 
glucose-6-phosphate in the liver extract was converted 
into glucose and inorganic phosphate. The inorganic 
phosphate liberated was determined with ammonium 
molybdate; ascorbic acid was used as reducing agent. 
Any molybdate excess was removed by the arsenite-
citrate reagent, so it could no longer react with other 
phosphate esters or with inorganic phosphate formed 
by the acid hydrolysis of the substrate. The amount of 
liberated phosphate per unit time, determined as the 
blue phosphor-molybdous complex at 700 nm, is a 
measure of the glucose-6-phosphatase activity. The 
glucose-6-phosphatase activity (mU) was expressed as 
mmol of phosphate released/min/ mg of protein. The 
standard curve was elaborated with a standard solution 
of inorganic phosphate in water. The protein content 
of the liver extract was quantified with Bradford 
reagent (Bradford, 1976). 
GK (glucokinase) activity was measured by 
spectrophotometry as previously described by Panserat 
et al., (2001). Briefly, liver tissues were homogenized  
and centrifuged, the supernatant was supplemented 
with 1 mM NADP, 5 mM ATP, and 100 mM or 0.5 
mM glucose at pH 7.5. The enzymatic reaction was 
started by the addition of 0.2 units of glucose-6-
phosphate dehydrogenase (E.C.l.l.l.49) and incubated 
for 5 min at 37º C. NADPH generated by GK was 
measured using a spectrophotometer at 340 nm. GK 
activity was estimated by the standard method, i.e. 
subtracting the rate of NADPH formation in the 
presence of 0.5 mM glucose from that obtained in the 
presence of 100 mM glucose.
 
Gk activity was 
estimated as the difference in activity when samples 
were assayed at 100 mmol/l (GK plus hexokinase 
activity) and 0.5 mmol/l glucose (hexokinase activity).  
Protein concentration was quantified with Bradford 
reagent (1976) and one unit of enzyme activity (mU) 
was defined as mmol of substrate molecules converted 
by 1 mg protein per minute.  
 
Measurements of reduced GSH, SOD, CAT and GPx 
The livers were homogenized with Ultra Turrax T25 
homogenizer (Rose Scientific Ltd., Edmonton, 
Canada) in 10 volumes of a 50 mM sodium phosphate 
buffer (PH 7.4) at 4º C. Homogenates were 
centrifuged (Beckman, USA) at 15000Xg for 10 min, 
and the supernatant obtained was used for antioxidant 
enzyme measurements. Antioxidant enzyme activities 
in the liver were assayed using commercial kits for 
superoxide dismutase (SOD) (Bioxytech kit), SOD-
525 for SOD activity (Oxis International), catalase 
(CAT) assay kit (Cayman Chemical), glutathione 
peroxidase assay kit Bioxytech GPx-340 (Oxis 
International), and glutathione reductase assay kit 
Bioxytech GR-340 (Oxis International).  
 
Determination of insulin  
Serum and pancreatic insulin was measured by a 
Glazyme Insulin-EIA Test (Zamami et al., 2008). 400 
mg/kg of hexane and chloroform P. michuacana bulbs 
extracts were orally administered to the rats for three 
weeks, after that time, blood samples were taken for 
insulin determination. Insulin concentration in serum 
is expressed in µIU/ml. The pancreas was rapidly 
excised, and homogenized in acidified ethanol. 
Samples were incubated at 4º C for 48 h with 
continuous shaking before the insulin test. 
 
Formation of AGE in the BSA/glucose 
P. michuacana extracts were evaluated for their 
potential glycation inhibitory activity, we performed  
this evaluation as previously described (Kim and Kim, 
2003). Bovine serum albumin (Sigma, USA) 
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(10mg/mL) was incubated with 250 mM D-fructose in 
the presence or absence of test materials for 21 days in 
0.2 M potassium phosphate buffer (pH 7.4) at 37º C. 
After incubation, the fluorescence was measured at an 
excitation wavelenght of 370 nm and an emission 
wavelenght of 440 nm. Both incubations and 
measurements were carried out by triplicate. 
Aminoguanidine (Sigma, USA) (AG) dissolved in 
distilled water was used as a positive control. The 
concentration of each test sample giving 50% 
inhibition of the activities (IC50) was estimated from 
the least-squares regression line of the logarithmic 
concentration plotted against the remaining activity. 
 
Statistical analysis 
Statistical calculations were done using one-way 
analysis of variance (ANOVA). Individual differences 
among groups were anayzed by Dunnett´s test using 
SPSS software. P values less than 0.05 were 
considered as statistically significant. Data a expressed 
as mean ± SEM for 6 rats in each group. 
 
RESULTS  
Toxicity evaluation 
The extracts did not show any mortality up to a dose 
of 3 g/kg body weight or any toxic reactions were 
found at any doses selected until the end of the study 
period. 
 
Effects of hexane, chloroform and methanol extracts 
on diabetic and nondiabetic rats 
Table 1 shows the level of blood glucose in STZ 
induced diabetic rats and no-diabetic rats at different 
time intervals. There was a significant increase in 
blood glucose level (p < 0.01) in diabetic rats after 24 
h of the STZ injection compared to the control group. 
Treatment with hexane extract of PM at 100, 200 and 
400 mg/kg, tolbutamide 40 mg/kg and glibenclamide 
0.5 mg/kg significantly decreased blood glucose in 
diabetic rats.  However, chloroform and methanol 
extracts have no effect on blood glucose levels. The 
percentage blood glucose reduction with 200 and 400 
mg/kg doses at 6 h was 35.75% and 47.78% 
respectively. Tolbutamide 40 mg/kg and gibenclamide 
0.5 mg/kg produced 46.74% and 39.82% respectively 
of blood glucose reduction after 6 h. Changes in the 
plasma glucose concentration are shown in Table 1.  
Maximum percentage blood glucose reduction 
to normoglycemic rats at 6 h with 400 mg/kg doses of 
hexane extract of P. michuacana was 57.10%. 
Tolbutamide 40 mg/kg dose produced 43.47% blood 
glucose reduction at 6 h in nondiabetic rats (Table 1). 
However, chloroform and methanol extracts to the 
same doses did not produced hypoglycemic activity. 
 
Oral Glucose Tolerance Test 
The postprandial blood glucose levels in rats showed a 
significant change after glucose loading. Oral 
administration of a glucose load (2 g/kg) rapidly 
increased blood glucose levels in all groups of diabetic 
rats within 30 min and remained high over the next 
120 min in diabetic control rats (Table 2), and at the 
end of the period, it did not come back to the initial 
value (0 min level). In both groups treated with the 
hexane extract, blood glucose level decreased 
significantly and after 60 minutes, this parameter was 
resettled to control level. 
 
Serum lipid profile  
Serum triglycerides, total cholesterol and TBARS 
levels were highly elevated in liver and kidney of 
diabetic rats while LDL-cholesterol was decreased 
(Table 3). There were also noticeable changes in 
serum lipids levels in the diabetic treated rats when 
compared with the untreated diabetic group. Daily 
administration of the hexane extract to diabetic and 
non-diabetic rats at a dose of 400 mg/kg for 28 days 
significantly reduced serum triglycerides and total 
cholesterol by 51% and 46% respectively. TBARS 
level in diabetic rats liver and kidney decreased upon 
administration of the hexane extract by 27.5% and 
25% in non-diabetic rats. Decreased LDL-cholesterol 
observed in diabetic animals was found to increase 
upon treatment. 
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Table 1 
Effect of hexane extract of bulbs of Prosthechea michuacana (PM) on fasting blood glucose level  
in diabetic rats 
 
Group          Dose                                               Blood glucose levels (mg/dl) at different time intervals (hours) 
                   (mg/kg)     At the time              2 h                 4 h                      6 h                    8 h                  12 h   
                                    of grouping          
 
NDC 
 
 ---- 
 
   103.41 ± 0.91a 
 
 
   102.30 ± 0.95 
 
 
100.21 ± 1.38   
 
 
  101.67 ±  0.98 
 
 
  99.65 ± 1.75 
 
 
  99.59 ±  0.85 
 
ND + PM 100 
 
200 
 
400 
 
   102.24 ± 0.97a 
 
   101.52 ± 2.02a 
 
   105.10 ± 0.89a 
       95.98 ± 4.83b 
 
         86.59 ± 5.04 a,c 
 
      82.25 ± 5.12 a,c 
 
  88.23 ± 2.57 b 
 
  54.26 ± 1.35 a,c 
 
  48.97 ± 1.46 a,c 
 
81.31 ±  2.54 a, 
 
50.11 ±  1.13 a,b 
 
45.08 ±  0.87 b,c 
 
  86.24 ± 3.35a 
 
  54.44 ± 2.06a,c  
 
  51.03 ± 2.46a,c 
 
  89.53 ± 1.65a 
 
  63.17 ± 0.84b 
 
  62.94 ± 0.48b 
 
ND + TB 
              
 40    99.34 ± 1.69b       76.12 ± 3.47 a,c 
 
58.34 ± 1.06 a,c 
 
55.23 ± 1.65 a,b 
 
  58.10 ± 2.44a,c 
 
  70.10 ± 1.23b,c 
 
 
DC   --     362.51 ± 1.89        349.47 ± 2.23 a 358.08 ± 3.76 b  339.32 ± 5.16 351.91 ±  2.32 341.56 ± 4.51 
 
D + PM 100 
 
200 
 
400 
   345.43 ± 2.32 a 
 
   358.19 ± 3.61 a 
 
   362.17 ± 3.80 a 
    334.21 ± 3.16 a 
 
     320.21 ± 5.25 b 
 
     300.95 ± 3.64b 
 
322.41 ± 3.30 a 
 
263.20 ± 1.80 c 
 
210.71 ± 4.04a 
 
 313.46 ± 3.76a         
 
 230.08 ± 4.35b 
 
 189.12 ± 5.21c 
 
316.43 ± 2.48a 
 
237.14 ± 3.70c  
 
202.19 ± 1.79a 
 
320.43 ± 3.12a 
 
251.31 ± 3.97b 
 
227.36 ± 2.78b 
 
D + TB  40    348.43 ± 4.07 a      275.32 ± 6.80 c 
 
213.23 ± 4.61a 
 
 185.60 ± 1.78c 
 
209.50 ± 2.57a 
 
244.27± 2.50b 
 
 
D + GB  0.5 
 
   336.62 ± 6.14a     269. 51 ± 7.20c 
 
194.48 ± 1.61a 
 
 202.6 ± 2.38c 
 
214.43± 2.12a 
 
259.22 ± 2.43b 
 
Each values represent Mean ± SD (n = 6), ANOVA followed by multiple two tail “t” test. In each column, mean 
with different superscripts (a, b, c) differ from each other significantly, p > 0.05. Those with the same letter are not 
significantly different at p > 0.05. Nomenclature of table: NDC: Non-diabetic Control; ND (Non-diabetic) + PM 
(Hexane extract from P. michuacana); ND + TB (Tolbutamide); DC: Diabetic Control; D + PM: Diabetic + PM; D 
(Diabetic) + TB: D + TB; D + GB (Gibenclamide).  
 
Table 2 
Effect of hexane extract of bulbs of Prosthechea michuacana on oral glucose tolerance test  
in diabetic rats 
 
                                                                                                   Blood glucose levels (mg/dl) 
 Groups                                  At the time              30 min              60 min               90 min               120 min 
                                             of grouping 
 No-diabetic 
 
  90.34 ± 1.65
b
 178.53 ± 2.06
a
 159.16 ± 1.47
a
 126.79 ± 1.76
a
    96.75 ± 0.96
a
 
 Diabetic control 
 
289.61 ± 3.48
 c
 365.08 ± 1.37
b
 421.23 ±  4.63
 c
 394.52 ± 4.83
 c
 360.27 ± 2.72
c
 
 Diabetic + PM 200 
 
239.29 ± 2.74
a
 301.47 ± 1.68
c
 246.52 ± 3.63
a
 189.31 ± 2.20
a
 142.39 ± 1.26
a
 
 Diabetic + PM 400 
 
221.07 ± 3.14
a
 299.86 ± 2.31
b
 217.58 ± 3.54
c
 167.73 ± 2.86
 c
 130.29 ± 1.47
c
  
Values are mean ± SD (n = 6).  ANOVA followed by multiple two tail “t” test. Line with (a, b, c) within fixed 
duration of measurement differ from each other significantly, p > 0.05. 
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Glycogen level, GK and Glucose 6-phosphatase 
activities           
Glycogen levels were significantly decreased in STZ 
induced diabetic rats compared to control group. After 
a 28 days period of administration of P. michuacana 
hexane extract there was a considerable elevation in 
the level of glycogen in liver and skeletal muscle 
compared to diabetic control rats and these parameters 
were resettled toward those of the control group (Table 
3). 
G6Pase and GK activities were increased in 
STZ induced diabetic rats compared to control (Table 
4). After the same 28 days treatment with the hexane 
extract, there was a significant diminution in these 
parameters by 55.0% and 52% respectively, and these 
parameters resettled toward those of the control group 
as well. 
 
Table 3 
Effect hexane extract bulbs of Prosthechea michuacana (PM) on lipid profile  
in STZ-induced diabetic rats 
 
                                                                                   Mean Concentration (mg/g) ± SEM  
      Group             Triglycerides        Total cholesterol     HDL-cholesterol             TBARS (µM/g) 
                (mg/kg)                 (mg/dl)                (mg/dl)                 (mg/dl)                Liver              Kidney 
          Normal  90.21 ± 3.43 128.71 ± 4.76  68.43 ± 1.75  0.98 ± 0.080 1.5 ± 0.096 
      Diabetic control 185.64 ± 5.11
a
 245.09 ± 2.84
 a
  34.61 ± 1.30
 a
  1.60 ± 0.042
 a
 2.3 ± 0.043
 a
 
         PM  200 129.56 ± 2.43
ab
 153.21 ± 3.48
ab
  50.18 ± 2.41
ab
  1.40 ± 0.024
ab
 1.9 ± 0.017
 ab
 
       PM 400  90.34 ± 6.21
ab
 132.15 ± 3.96
ab
   56.37 ± 1.84
ab
  1.00 ± 0.056
ab
 1.6 ± 0.045
 ab
 
All values are expressed as Mean ± SEM, n = 6 Values. 
a
P < 0.05 when compared to normal control group,   
b
P < 0.01when compared to diabetic control group, where the significance was performed by Oneway ANOVA 
followed by post hoc Dunnett´s test. 
 
 
Table 4 
Effect of hexane extract of Prosthechea michuacana (PM) on hepatic glucose regulation enzyme activities 
profile and glycogen content of liver and skeletal muscle in STZ induced diabetic  rats 
 
               Treatment                  Glucose 6-phosphatase     Glucokinase                Mean Concentration (mg/g) ± SEM 
 (mg/kg )  activity (mU)        activity (mU)              Liver glycogen        Skeletal muscle 
Normal control 
 
0.38 ± 0.18
 
 3.23 ± 0.08
 
 
 
18.56 ± 0.26 12.24 ± 0.32 
Diabetic Control 
 
 0.69 ± 0.69
a 
 1.19 ± 2.04
a  
 
   8.24 ± 1.37
a
    3.98 ± 3.25
 a
 
Diabetic+PM 200  0.41 ± 0.38
b
 
 
1.94 ± 2.03
b
 
 
14.83 ± 0.25
 b
    9.35 ± 0.57
 b
 
Diabetic+PM 400 0.33 ± 0.74
b
 
 
2.91 ± 1.71
b
 
 
16.98 ± 0.47
 b
 11.27 ± 0.38
 b
 
Glibenclamide 
(4 mg/kg) 
0.36 ± 0.49
b
    3.10 ± 0.51 
 
17.67 ± 0.29
 b
 12.01 ± 0.41
 b
 
Each values represent Mean ± SD, (n = 6); ANOVA followed by multiple two tail “t” test. In each  vertical column, 
mean with different superscripts (a, b) differ from each other.All values are expressed  as Mean ± SD, n = 6 Values. 
Significant difference of diabetic control from normal control 
a
P < 0.001.Significant difference of treated groups from 
diabetic control 
b
P < 0.01, 
c
P < 0.05. 
d
P < 0.01 when compared  with glibenclamide 4 mg/kg treated group. 
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Effect of P. michuacana hexane extract on SOD, 
CAT, GSH and GPx in hepatic and renal tissues 
The antioxidant effect of the extract on tissue 
antioxidant markers was studied (Table 5). The 
diabetic rats showed an important reduction in 
SOD, CAT, GSH and GPx in hepatic and renal 
tissues. The decreased levels of SOD, CAT, GSH 
and GPx in diabetic rats were found to be reverted 
to near normal levels after treatment with bulbs 
extract. The levels of these enzymes quantified in 
treated groups were comparable to those attained 
with the standard drug glibenclamide. 
 Administration of P. michuacana to diabetic 
rats showed a significant effect, and restored the 
activities of liver and kidney regarding these 
parameters.  
 
Table 5 
Effect hexane extract bulbs of Prosthechea michuacana (PM) on antioxidant enzyme activities 
in liver and kidney in diabetic rats 
 
Parameters Normal 
Control 
Diabetic 
control 
Diabetic+PM Diabetic+PM Diabetic+ 
GB 
   (200 mg/kg) (400 mg/kg) (5 mg/kg) 
SOD-Liver 7.12 ± 3.42 3.76 ± 0.25
a
 5.87 ± 1.06
c
 6.59 ± 1.65
b
 6.78 ± 0.21
c
 
SOD-Kidney 13.97 ± 2.65
 
 7.02 ± 1.86
a
 9.78 ± 0.65
b
 12.45 ± 1.67
b
 12.99 ± 0.16
b
 
CAT-Liver 81.25 ± 4.09 44.36 ± 1.34
a
 59.85 ± 0.96
c
 69.87 ± 5.17
b
 70.09 ± 0.78
b
 
CAT-Kidney 35.21 ± 3.77 20.10 ± 0.95
a
 30.04 ± 0.78
a
 33.87 ± 3.21
c
 34.12 ± 1.44
b
 
GSH –Liver 46.31 ± 1.16 22.35 ± 1.92a 35.41 ± 1.83b 42.05 ± 1.67b 41.38 ± 2.65b 
GSH –Kidney 23.62 ± 2.31 5.53 ± 0.79a 15.61 ± 0.89b 19.15 ± 2.43b 19.46 ± 0.83b 
GPx –Liver 7.56 ± 3.26 4.68 ± 0.87a  5.25 ± 1.38c 5.67 ± 4.30b 5.89 ± 1.52b 
GPx –Kidney 5.89 ± 1.32 3.49 ± 1.36a 4.11 ± 0.43b 4.67 ± 2.36b 4.53 ± 2.16b 
 
All values are expressed as Mean ± SEM, n = 6 Values. 
a
P < 0.01 when compared to normal control group; 
b
P < 0.01; 
c
P < 0.05 compared to diabetic control group; where the significance was 
performed by Oneway ANOVA followed  by post hoc Dunnett´s test. Glibenclamide (GB).  
The values are given in U/mg of protein 
 
Effect of P. michuacana on serum insulin level and 
pancreatic insulin content 
Serum insulin level and pancreatic insulin content 
were significantly decreased in STZ-induced diabetic 
rats compared to control. After three weeks of 
administration of the hexane extract of P. michuacana 
there was a noticeable elevation in serum and 
pancreatic insulin level. This is shown in Table 6. 
 
Table 6 
Effect of hexane extract from seeds of Prosthechea michuacana (PM) on plasma insulin level and pancreatic 
insulin content in diabetic rats 
 
Groups Plasma insulin Pancreatic insulin 
 (µU/ml) (mU/g protein) 
Nodiabetic control 3.52 ± 0.42 25.12 ± 1.65 
Diabetic control 1.20 ± 0.31
a
 
d
14.53 ± 3.65
 a
 
PM  200 2.60 ±  0.47
c
 
d
20.42 ± 2.78
 b
 
PM 400 3.20 ± 0.31
b
 
d
24.15 ± 1.98
b
 
Glibenclamide 
4 mg/kg 
3.38 ± 0.19
 b
 15.03 ± 3.62
b
 
All values are expressed as Mean ± SD, n = 6 Values. Significant difference of diabetic control from normal control 
a
P < 0.001. Significant difference of treated groups from diabetic control 
b
P < 0.01, 
c
P < 0.05. 
d
P < 0.01when 
compared with glibenclamide 4 mg/kg treated group. 
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Effect of PM on AGEs and hemoglobin lycosylation   
Table 7 shows the effect of the hexane extract on 
hemoglobin glycosylation and inhibition of AGEs. 
The BSA-glucose in vitro model adopted in this study 
provides a useful tool for assessing the effect of 
extracts on nonoenzymatic glycation process. Hexane 
extract of P. michuacana bulbs, reduced AGEs 
formation with IC50 values of 48.3 µg/ml comparable 
to the inhibitory effect of aminoguanidine with IC50 
values of 27.2 µg/ml. Aminoguanidine is an AGE 
inhibitor tested in clinical trials for the treatment of 
diabetic complications. The concentration of 
carbohydrate bound to hemoglobin was increased in 
the diabetic group. However, chronic treatment with 
P. michuacana extract caused a significant (p < 0.05) 
reduction in the absorbance of 5-hydraxyrnethyl 
furfural (5-HMF) generated from hemoglobin-bound 
sugar in diabetic rats. 
 
Table 7 
Effect of hexane extract of bulbs of Prosthechea michuacana (PM) on plasma levels of  
            HbA1c in chronic diabetic rats 
 
Treatment Baseline (%) HbA1c (%) 
No-diabetic 3.8 3.9 
Diabetic Control 4.1
a
 8.5
 a
 
Diabetic + insulin 4.3
 b
 7.1
 b
 
Diabetic+ PM (400 mg/kg) 4.2
 b
 
b
6.9
 b
 
Glibenclamide 
4 mg/kg 
4.4
 b
 7.3
 b
 
All values are expressed as Mean ± SD, n = 6 Values. 
Significant difference of diabetic control from normal control 
a
P < 0.001. 
Significant difference of treated groups from diabetic control 
b
P < 0.01, 
c
P < 0.05. 
d
P < 0.01 when compared with  
glibenclamide 4 mg/kg treated group. 
 
DISCUSSION AND CONCLUSION 
In the present study we wanted to test the efficacy of 
an hexane extract of bulbs of P. michuacana in 
correcting physiological disorders caused by STZ-
induced diabetes in rats, where β-cell degeneration is 
dramatic (diabetes type 1). Diabetes is associated with 
hyperlipidemia, here we show the antihyperlipidemic 
efficacy and potency of the extracts in STZ-induced 
diabetic rats evidenced by the decrease of total 
cholesterol, and triglycerides levels, after the extract 
administration. Furthermore, the attenuating effect of 
this extract on experimental STZ-induced diabetes has 
been confirmed here by the study of glucose-6-
phosphatase activity in liver, as well as the 
quantification of glycogen in liver and skeletal muscle, 
which are important indicators of diabetes mellitus 
(Boby
 
et al., 2003).
 
These effects may be due to low 
activity of cholesterol biosynthesis enzymes and/ or 
low level of lipolysis which are under the control of 
insulin (Huang et al., 2000). 
The possible mechanism of antihyperglycemic 
action of this extract appears to be both pancreatic and 
extra pancreatic, which have been supported here by 
the serum insulin assay in STZ-induced diabetic rats. 
The extra pancreatic effect of this extract was 
evaluated by the significant recovery of glucose-6-
phosphatase activity in liver in STZ-induced diabetic 
rats. The extra pancreatic effect may be due to the 
sensitization of insulin receptor in target organ or by 
inhibition of insulinase activity in both liver and 
kidney. From the glucose tolerance test we have 
learned that the hexane extract did not execute the 
antihyperglycemic effect by modulating the absorption 
of glucose in the intestine. 
Hyperglycemia induced oxidative stress may 
also cause liver cell damage. The administration of 
extracts improves impairments of SOD, GSH, GSSG 
and CAT activities in the STZ-induced diabetic group. 
These results suggest that the hexane extract prevents 
oxidative stress, acting as a suppressor against liver 
cell damage and inhibiting the progression of liver 
dysfunction induced by chronic hyperglycemia 
(Narvaez-Mastache et al., 2007).  
Chronic hyperglycemia leads to the auto-
oxidation of glucose and causes nonenzymatic 
glycation of proteins through Maillard´s reaction (Goh 
and Cooper, 2008). In these processes, reactive oxygen 
species are produced. To avoid oxidative stress, 
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antioxidant enzymes, such as catalase, superoxide 
dismutase, and glutathione peroxidase, play an 
important role against oxidative stress. However, 
hyperglycemia also causes nonenzymatic glycation of 
these antioxidant enzymes (Jagtap and Patil, 2010). 
Furthermore, AGE formation, one of the metabolic 
disorders caused by hyperglycemia, has been focused 
on as a marker of long-term glycemic control in body 
tissues. Our study found that hexane extract of P. 
michuacana could inhibit the formation of AGEs, 
which have been implicated in the pathogenic process 
of diabetic complications. The inhibition of AGEs 
formation was comparable to that obtained by using 
the standard antiglycation agent aminoguanidine. The 
glycosylated serum hemoglobin of diabetic control rats 
was significantly increased relative to the control 
levels. Treatment of P. michuacana decreased 
formation of glycated hemoglobin. Therefore, we 
considered that P. michuacana, might have influence 
on AGEs formation. The possible mechanisms of this 
must be clarified in future studies. 
 
CONCLUSION 
Our study demonstrated that P. michuacana exhibited 
hypoglycemic activity through improving 
hyperlipidemia, insulin resistance, and improving the 
antioxidant defense system. Our findings strongly 
suggest that the inhibition of oxidative stress and AGE 
formation would be also very helpful preventing 
diabetes complications. Therefore, P. michuacana can 
be considered as a plant with an enormous potential as 
an anti-diabetic agent; however the investigation of its 
major active constituents is still in progress.  
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